Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (1y) (2011 - 2026)
Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -286.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 6,388.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 200.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -41.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 879.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -2,494.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 632.00 |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 216.00 |
| 10 | Bio-Rad Laboratories | 10.07 Bn | 8.45 Bn | 345.80 Mn | 35,327.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35,327.00 |
| Mar 31, 2026 | -499.00 |
| Dec 31, 2025 | -567.00 |
| Mar 31, 2025 | -121,547.00 |
| Dec 31, 2024 | 20.00 |
| Mar 31, 2024 | 121,471.00 |
| Dec 31, 2023 | -288.00 |
| Sep 30, 2023 | -91.00 |
| Jun 30, 2023 | -123.00 |
| Mar 31, 2023 | -184.00 |
| Dec 31, 2022 | 351.00 |
| Sep 30, 2022 | 72.00 |
| Jun 30, 2022 | 48.00 |
| Mar 31, 2022 | 129.00 |
| Dec 31, 2021 | -235.00 |
| Sep 30, 2021 | 44.00 |
| Jun 30, 2021 | 87.00 |
| Mar 31, 2021 | 362.00 |
| Dec 31, 2020 | 424.00 |
| Sep 30, 2020 | 374.00 |